Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie’s disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg) will be shared during the Sexual Medicine Society of North America (SMSNA) annual meeting, taking place November 16-19 in San Diego.
November 16, 2023
· 12 min read